COMPARE · Data as of August 24, 2026
HNGE vs OMCL
Verdict: Side-by-side breakdown using the Bull Rankings model. HNGE scored 72.0, OMCL scored 52.6 — HNGE leads.
Compare another set
HNGE
Hinge Health, Inc.
72
$88.42 · $7.1B
fundamentals as of
Score gap
19.4
HNGE leads
OMCL
Omnicell, Inc.
52.6
$34.66 · $1.6B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestHNGE10.8x
- Fastest growthHNGE+49.8%
- Strongest balance sheetHNGE0.02
- Highest qualityHNGE97 / 100
- Largest discount to fair valueOMCL-11%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
HNGE
stronger →← stronger
OMCL
97
Qualityreturns · margins · balance sheet
48
66
Growthrevenue & earnings expansion
59
71
Valuevaluation vs sector peers
51
HNGE is stronger on 3 of 3 pillars.
Fundamentals, head-to-head
HNGE
OMCL
$290mC
FCF
$143mC
+49.8%A
Rev
+8.5%B
0.02A-
D/E
0.15B+
10.8xA
P/E
42.3xC
0.36A
PEG
15.40D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
HNGE
OMCL
5% above
Price vs fair valuelower is cheaper
11% below
~16%/yr
Growth the price implies10-yr FCF · lower = less priced in
~-4%/yr
-27%
1-yr DCF upside
+25%
-5%
5-yr DCF upside
+13%
+43%
10-yr DCF upside
-3%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
HNGE
Why this score
- Short track record
OMCL
No notable signals flagged.
The companies
HNGEHinge Health, Inc.
Why now
Health Information Services · market cap $7.1b. 5% off the 52-week high of $93.13. Revenue growing +50% — in hypergrowth territory. PEG 0.36 — paying under fair value for the growth rate. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $106.47 (implying +20% upside).
Moat
Net margin 15% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 32% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
OMCLOmnicell, Inc.
Why now
Health Information Services · market cap $1.6b. Down 37% from 52-week high of $55.00 — deep drawdown territory. 7 sell-side analysts publish a mean 1-yr target of $57.86 (implying +67% upside).
Moat
Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Down 37% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 42x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Net margin 3.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where HNGE and OMCL diverge
On the headline score the gap is 19.4 points in favor of HNGE. The widest single difference is Quality, where HNGE leads by 49.0 points.
- QualityHNGE 96.5 · OMCL 47.5HNGE +49.0
- ValueHNGE 70.7 · OMCL 51.4HNGE +19.3
- GrowthHNGE 66.3 · OMCL 59.5HNGE +6.8
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.